Hepatitis Monthly

Published by: Kowsar

Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters

Nazlim Aktug Demir 1 , Servet Kolgelier 2 , Serap Ozcimen 3 , Gokhan Gungor 4 , Sua Sumer 1 , * , Lutfi Saltuk Demir 5 , Ahmet Cagkan Inkaya 6 and Onur Ural 1
Authors Information
1 Infectious Diseases and Clinical Microbiology Department, Selcuk University, Konya, Turkey
2 Infectious Diseases and Clinical Microbiology Department, Adiyaman University, Adiyaman, Turkey
3 Infectious Diseases and Clinical Microbiology Department, Konya State Hospital, Konya, Turkey
4 Gastroenterology Department, Konya Education and Training Hospital, Konya, Turkey
5 Public Health Department, Necmettin Erbakan University, Konya, Turkey
6 Infectious Diseases and Clinical Microbiology Department, Hacettepe University, Ankara, Turkey
Article information
  • Hepatitis Monthly: April 01, 2014, 14 (4); e16975
  • Published Online: April 1, 2014
  • Article Type: Research Article
  • Received: December 17, 2013
  • Revised: February 24, 2014
  • Accepted: March 6, 2014
  • DOI: 10.5812/hepatmon.16975

To Cite: Demir N A, Kolgelier S, Ozcimen S, Gungor G, Sumer S, et al. Evaluation of the Relation Between Hepatic Fibrosis and Basic Laboratory Parameters in Patients With Chronic Hepatitis B Fibrosis and Basic Laboratory Parameters, Hepat Mon. 2014 ; 14(4):e16975. doi: 10.5812/hepatmon.16975.

Copyright © 2014, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006; 45(4): 529-38[DOI][PubMed]
  • 2. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol. 2004; 99(6): 1160-74[DOI][PubMed]
  • 3. Smith JO, Sterling RK. Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment Pharmacol Ther. 2009; 30(6): 557-76[DOI][PubMed]
  • 4. Thampanitchawong P, Piratvisuth T. Liver biopsy:complications and risk factors. World J Gastroenterol. 1999; 5(4): 301-4[PubMed]
  • 5. Campbell MS, Reddy KR. Review article: the evolving role of liver biopsy. Aliment Pharmacol Ther. 2004; 20(3): 249-59[DOI][PubMed]
  • 6. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995; 22(6): 696-9[PubMed]
  • 7. Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003; 38(2): 518-26[DOI][PubMed]
  • 8. Guma JR, Marti V, Bailen JL, Padro JM, Garcia J, Auge JM. [The single coronary artery. Presentation of a case]. Rev Esp Cardiol. 1990; 43(3): 201-2[PubMed]
  • 9. Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH, et al. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology. 2011; 53(3): 726-36[DOI][PubMed]
  • 10. Hui AY, Chan HL, Wong VW, Liew CT, Chim AM, Chan FK, et al. Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model. Am J Gastroenterol. 2005; 100(3): 616-23[DOI][PubMed]
  • 11. Halfon P, Bourliere M, Deydier R, Botta-Fridlund D, Renou C, Tran A, et al. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study. Am J Gastroenterol. 2006; 101(3): 547-55[DOI][PubMed]
  • 12. McCuskey RS. Preface. Comp Hepatol. 2004; 3 Suppl 1[DOI][PubMed]
  • 13. Halfon P, Bourliere M, Penaranda G, Deydier R, Renou C, Botta-Fridlund D, et al. Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol. 2005; 4: 6[DOI][PubMed]
  • 14. Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem. 2004; 50(8): 1344-55[DOI][PubMed]
  • 15. Giannini E, Risso D, Testa R. Transportability and reproducibility of the AST/ALT ratio in chronic hepatitis C patients. Am J Gastroenterol. 2001; 96(3): 918-9[DOI][PubMed]
  • 16. Iacobellis A, Fusilli S, Mangia A, Clemente R, Festa V, Giacobbe A, et al. Ultrasonographic and biochemical parameters in the non-invasive evaluation of liver fibrosis in hepatitis C virus chronic hepatitis. Aliment Pharmacol Ther. 2005; 22(9): 769-74[DOI][PubMed]
  • 17. Mohamadnejad M, Montazeri G, Fazlollahi A, Zamani F, Nasiri J, Nobakht H, et al. Noninvasive markers of liver fibrosis and inflammation in chronic hepatitis B-virus related liver disease. Am J Gastroenterol. 2006; 101(11): 2537-45[DOI][PubMed]
  • 18. Lu LG, Zeng MD, Mao YM, Li JQ, Qiu DK, Fang JY, et al. Relationship between clinical and pathologic findings in patients with chronic liver diseases. World J Gastroenterol. 2003; 9(12): 2796-800[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments